Skip to main content

Medicaid Provider Telemedicine

WellCare of Georgia is proud to announce a new service that will enhance the ability of our members in rural communities to access the health care services they need. 

WellCare has partnered with the Georgia Partnership for TeleHealth, Inc. (GPT), a charitable nonprofit corporation. GPT was formed to promote improvements in health care and health care facilities in rural and underserved communities throughout Georgia by establishing telemedicine programs. 

Telemedicine makes it possible for members in remote locations to receive specialty services without traveling long distances. By leveraging technology, patients can connect with doctors using video technology at a site close to the member's home. 

WellCare's partnership with GPT will provide our members access to one of the most comprehensive telemedicine networks in the nation, with over 200 specialists covering 40+ specialties throughout the state of Georgia. This will enable patients in remote locales to access care easier and earlier, thus reducing the instances - and associated physical and financial costs - of untreated health care problems. 

As a primary care provider, GPT will give you another option when coordinating specialty care for your patients in remote areas. Members will be instructed to contact their physician to gain access to telemedicine services. To minimize the impact on you and your staff, WellCare does not require authorization for referrals to TeleHealth specialists. 

Very soon, our members will be receiving information about this service. Please make sure your staff is familiar with the program should one of your patients inquire about it. For further information regarding GPT, participating providers and a list of presenting sites, please visit the GPT website

As always, we thank you for your valued partnership in delivering quality health care that improves the health and lives of our members. 

Contact Us icon

Need help? We're here for you.

Contact Us
Last Updated On: 12/3/2020